Seul-Gi Kim Selected Research

Gamma Cameras (Gamma Camera)

1/2022	A novel dual-labeled small peptide as a multimodal imaging agent for targeting wild-type EGFR in tumors.
1/2021	Dual-labeled prostate-specific membrane antigen (PSMA)-targeting agent for preoperative molecular imaging and fluorescence-guided surgery for prostate cancer.
8/2019	A novel dual-modality imaging agent targeting folate receptor of tumor for molecular imaging and fluorescence-guided surgery.
10/2018	Tc-99m and Fluorescence-Labeled Anti-Flt1 Peptide as a Multimodal Tumor Imaging Agent Targeting Vascular Endothelial Growth Factor-Receptor 1.
1/2018	A novel Tc-99m and fluorescence-labeled arginine-arginine-leucine-containing peptide as a multimodal tumor imaging agent in a murine tumor model.
12/2017	Synthesis and evaluation of Tc-99m and fluorescence-labeled elastin-derived peptide, VAPG for multimodal tumor imaging in murine tumor model.
11/2016	A novel Tc-99 m and fluorescence labeled peptide as a multimodal imaging agent for targeting angiogenesis in a murine tumor model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Seul-Gi Kim Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 11/2016
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2018 - 11/2018
1	Pathologic Complete Response 07/2022
1	Breast Neoplasms (Breast Cancer) 07/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Hypernatremia 11/2019
1	Water Intoxication 11/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2019
1	Melanoma (Melanoma, Malignant) 02/2019
1	Ischemia 03/2017
1	Hemoptysis 02/2017
1	Tuberculosis (Tuberculoses) 02/2017
1	Peripheral Nervous System Diseases (PNS Diseases) 04/2016
1	Ototoxicity 04/2016
1	Deaf-Blind Disorders 04/2016
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 04/2016
1	Lymphoma (Lymphomas) 01/2015
1	Hearing Loss (Hearing Impairment) 01/2015
1	Multiple Myeloma 01/2015
1	Bilateral Hearing Loss 01/2015
1	Dyslipidemias (Dyslipidemia) 12/2013
1	Starvation 12/2013
1	Type 2 Diabetes Mellitus (MODY) 07/2011

Drug/Important Bio-Agent (IBA)

6	Peptides (Polypeptides)IBA 01/2022 - 11/2016
2	Protein Glutamine gamma Glutamyltransferase 2IBA 11/2018 - 11/2018
1	Carboplatin (JM8)FDA LinkGeneric 07/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	tetramethylrhodamine (T 489)IBA 01/2022
1	AntigensIBA 01/2021
1	SodiumIBA 11/2019
1	hydroxide ionIBA 11/2019
1	Folic Acid (Vitamin M)FDA LinkGeneric 08/2019
1	NAD (NADH)IBA 02/2019
1	oxoglutarate translocatorIBA 02/2019
1	malic acid (malate)IBA 02/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2019
1	Adenosine Triphosphate (ATP)IBA 02/2019
1	Streptonigrin (Nigrin)IBA 11/2018
1	3- (phenylethynyl)- 2- (2- (pyridin- 2- yl)ethoxy)pyrido(3,2- b)pyrazineIBA 11/2018
1	PyrazinesIBA 11/2018
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 10/2018
1	Leucine (L-Leucine)FDA Link 01/2018
1	Arginine (L-Arginine)FDA Link 01/2018
1	ElastinIBA 12/2017
1	valyl-alanyl-prolyl-glycineIBA 12/2017
1	IntegrinsIBA 11/2016
1	CobaltIBA 04/2016
1	CytokinesIBA 04/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2016
1	Bortezomib (Velcade)FDA Link 01/2015
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2015
1	Proteasome InhibitorsIBA 01/2015
1	Fenofibrate (CiL)FDA LinkGeneric 12/2013
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2013
1	Triglycerides (Triacylglycerol)IBA 12/2013
1	GinsenosidesIBA 07/2011
1	AMP-Activated Protein KinasesIBA 07/2011
1	Orphan Nuclear ReceptorsIBA 07/2011

Therapy/Procedure

7	Gamma Cameras (Gamma Camera) 01/2022 - 11/2016
1	Vitrectomy 02/2017
1	General Anesthesia 02/2017
1	Therapeutics 01/2015